Logo image of IBTA

IBOTTA INC-CL A (IBTA) Stock Fundamental Analysis

NYSE:IBTA - New York Stock Exchange, Inc. - US4510511060 - Common Stock - Currency: USD

46.44  +0.31 (+0.67%)

After market: 46.44 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to IBTA. IBTA was compared to 98 industry peers in the Media industry. While IBTA has a great health rating, its profitability is only average at the moment. IBTA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

IBTA had negative earnings in the past year.
In the past year IBTA had a positive cash flow from operations.
IBTA Yearly Net Income VS EBIT VS OCF VS FCFIBTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

The Return On Assets of IBTA (9.39%) is better than 91.84% of its industry peers.
IBTA has a Return On Equity of 14.95%. This is amongst the best in the industry. IBTA outperforms 80.61% of its industry peers.
IBTA has a Return On Invested Capital of 2.11%. This is comparable to the rest of the industry: IBTA outperforms 52.04% of its industry peers.
Industry RankSector Rank
ROA 9.39%
ROE 14.95%
ROIC 2.11%
ROA(3y)-2.02%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBTA Yearly ROA, ROE, ROICIBTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 50 -50 100 150

1.3 Margins

Looking at the Profit Margin, with a value of 16.24%, IBTA belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
With a Operating Margin value of 2.93%, IBTA perfoms like the industry average, outperforming 47.96% of the companies in the same industry.
Looking at the Gross Margin, with a value of 84.66%, IBTA belongs to the top of the industry, outperforming 94.90% of the companies in the same industry.
Industry RankSector Rank
OM 2.93%
PM (TTM) 16.24%
GM 84.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IBTA Yearly Profit, Operating, Gross MarginsIBTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40 60 80

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IBTA is destroying value.
The number of shares outstanding for IBTA has been increased compared to 1 year ago.
There is no outstanding debt for IBTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IBTA Yearly Shares OutstandingIBTA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
IBTA Yearly Total Debt VS Total AssetsIBTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 4.26 indicates that IBTA is not in any danger for bankruptcy at the moment.
IBTA has a better Altman-Z score (4.26) than 83.67% of its industry peers.
IBTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.26
ROIC/WACC0.23
WACC9.08%
IBTA Yearly LT Debt VS Equity VS FCFIBTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 2.69 indicates that IBTA has no problem at all paying its short term obligations.
IBTA's Current ratio of 2.69 is amongst the best of the industry. IBTA outperforms 85.71% of its industry peers.
IBTA has a Quick Ratio of 2.69. This indicates that IBTA is financially healthy and has no problem in meeting its short term obligations.
IBTA has a better Quick ratio (2.69) than 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 2.69
IBTA Yearly Current Assets VS Current LiabilitesIBTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

IBTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 103.05%, which is quite impressive.
Looking at the last year, IBTA shows a quite strong growth in Revenue. The Revenue has grown by 14.75% in the last year.
EPS 1Y (TTM)103.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.82%
Revenue 1Y (TTM)14.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.73%

3.2 Future

Based on estimates for the next years, IBTA will show a very strong growth in Earnings Per Share. The EPS will grow by 136.53% on average per year.
The Revenue is expected to grow by 11.36% on average over the next years. This is quite good.
EPS Next Y534.37%
EPS Next 2Y228.63%
EPS Next 3Y136.53%
EPS Next 5YN/A
Revenue Next Year3.2%
Revenue Next 2Y8.97%
Revenue Next 3Y11.36%
Revenue Next 5YN/A

3.3 Evolution

IBTA Yearly Revenue VS EstimatesIBTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
IBTA Yearly EPS VS EstimatesIBTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1 1.5 2 2.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IBTA. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 22.63, the valuation of IBTA can be described as rather expensive.
IBTA's Price/Forward Earnings is on the same level as the industry average.
IBTA's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.39.
Industry RankSector Rank
PE N/A
Fwd PE 22.63
IBTA Price Earnings VS Forward Price EarningsIBTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IBTA indicates a slightly more expensive valuation: IBTA is more expensive than 62.24% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IBTA indicates a somewhat cheap valuation: IBTA is cheaper than 70.41% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.74
EV/EBITDA 53.01
IBTA Per share dataIBTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IBTA's earnings are expected to grow with 136.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y228.63%
EPS Next 3Y136.53%

More info and screens

0

5. Dividend

5.1 Amount

IBTA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IBOTTA INC-CL A

NYSE:IBTA (6/10/2025, 8:04:01 PM)

After market: 46.44 0 (0%)

46.44

+0.31 (+0.67%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-13 2025-08-13
Inst Owners48.36%
Inst Owner Change2.57%
Ins Owners17.92%
Ins Owner Change4.02%
Market Cap1.32B
Analysts76
Price Target61.71 (32.88%)
Short Float %15.39%
Short Ratio4.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)326.48%
Min EPS beat(2)46.79%
Max EPS beat(2)606.17%
EPS beat(4)3
Avg EPS beat(4)160.67%
Min EPS beat(4)-52.55%
Max EPS beat(4)606.17%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.94%
Min Revenue beat(2)-6.93%
Max Revenue beat(2)1.04%
Revenue beat(4)3
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-6.93%
Max Revenue beat(4)2.8%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.26%
PT rev (3m)-5.1%
EPS NQ rev (1m)-22.08%
EPS NQ rev (3m)-43.82%
EPS NY rev (1m)-21.74%
EPS NY rev (3m)-55.17%
Revenue NQ rev (1m)0.98%
Revenue NQ rev (3m)-0.48%
Revenue NY rev (1m)0.9%
Revenue NY rev (3m)-6.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 22.63
P/S 3.58
P/FCF 12.74
P/OCF 11.35
P/B 3.29
P/tB 3.29
EV/EBITDA 53.01
EPS(TTM)-0.08
EYN/A
EPS(NY)2.05
Fwd EY4.42%
FCF(TTM)3.65
FCFY7.85%
OCF(TTM)4.09
OCFY8.81%
SpS12.99
BVpS14.1
TBVpS14.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.39%
ROE 14.95%
ROCE 2.44%
ROIC 2.11%
ROICexc 6.43%
ROICexgc 6.43%
OM 2.93%
PM (TTM) 16.24%
GM 84.66%
FCFM 28.07%
ROA(3y)-2.02%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 152.38%
Cap/Sales 3.44%
Interest Coverage 250
Cash Conversion 607.79%
Profit Quality 172.85%
Current Ratio 2.69
Quick Ratio 2.69
Altman-Z 4.26
F-Score5
WACC9.08%
ROIC/WACC0.23
Cap/Depr(3y)126.83%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.82%
EPS Next Y534.37%
EPS Next 2Y228.63%
EPS Next 3Y136.53%
EPS Next 5YN/A
Revenue 1Y (TTM)14.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.73%
Revenue Next Year3.2%
Revenue Next 2Y8.97%
Revenue Next 3Y11.36%
Revenue Next 5YN/A
EBIT growth 1Y-50.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year213.61%
EBIT Next 3Y75.4%
EBIT Next 5YN/A
FCF growth 1Y629.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y410.29%
OCF growth 3YN/A
OCF growth 5YN/A